Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02
Article
Chen, Huanwen, Kuhn, John, Lamborn, Kathleen R et al. Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02
. 2(1), 10.1093/noajnl/vdaa124
Chen, Huanwen, Kuhn, John, Lamborn, Kathleen R et al. Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02
. 2(1), 10.1093/noajnl/vdaa124
Chen, Huanwen; Kuhn, John; Lamborn, Kathleen R; Abrey, Lauren E; DeAngelis, Lisa M; Lieberman, Frank; Robins, H Ian; Chang, Susan M; Yung, WK Alfred; Drappatz, Jan; Mehta, Minesh P; Levin, Victor A; Aldape, Kenneth; Dancey, Janet E; Wright, John J; Prados, Michael D; Cloughesy, Timothy F; Wen, Patrick Y; Gilbert, Mark R